June 29 is World Scleroderma Day every year. Its aim is to increase public knowledge about the disease, its symptoms and available treatments. A rare, chronic, inflammatory connective tissue disease called scleroderma Multiple sclerosis causes extra collagen to build up. Its course can vary from person to person, ranging from mild, bothersome symptoms to severe, complicated disease. Experimental treatments are being developed in addition to the treatment options currently available.
The main features of scleroderma are thickening of the skin and fibrosis of all organs. Fatigue, arthralgia, myalgia and Raynaud's phenomenon (a decrease in blood supply to the fingers that causes a feeling of coldness or numbness, sometimes affecting other areas of the body as well) are just some of the symptoms that can occur due to scleroderma affecting blood vessels and tissues throughout the body. The skin, lungs, heart, kidneys and digestive tract can all be affected by scleroderma.
Malnutrition is a common symptom due to reduced absorption of nutrients
There is currently no known data. scleroderma cureAlthough there are a number of approved medications that can help manage symptoms, including bosentan, nintedanib, and tocilizumab. Although there are other treatment options currently in development, the way of life Scleroderma can also impact the course of the disease. Chronic disease prevention and overall health can be greatly influenced by lifestyle choices. A healthy body weight can be maintained and proper growth, development, and aging can be supported through diet and exercise. Patients with scleroderma frequently suffer from malnutrition, which can be caused by reduced food absorption due to gastrointestinal problems.
Experimental treatments are currently being developed for scleroderma, in addition to lifestyle modifications. A first-in-class humanized monoclonal antibody called CM-101 from Chemomab Therapeutics is one possible treatment currently in development. The FDA has granted Paracrine Inc. approval to conduct a pivotal study using adipose-derived regenerative cells to treat patients with diffuse cutaneous scleroderma for hand impairment.
Early diagnosis of scleroderma is also crucial. After diagnosis, patients can begin treatment and make lifestyle changes that will help manage their pain and symptoms. There are many physical exams and diagnostic techniques to identify scleroderma. Physical exams can help identify distinctive indicators of the disease, such as skin thickness, especially on the hands and face. Blood tests, skin biopsies, imaging tests, pulmonary function tests, and nailfold capillaroscopies are among the required diagnostic procedures.
One of the main aims of World Scleroderma Day is to raise awareness of the symptoms of the disease and possible treatments. This will help people decide whether they should see a doctor and what options are available.
